Biogen Pharmachem Industries Ltd Q1 FY2024-2025 Results: Summary
Revenue | ₹0.09Cr |
Net Profits | ₹0.16Cr |
Net Profit Margins | 177.78% |
Highlights
Revenue:
Biogen Pharmachem Industries Ltd’s revenue fell -112% since last year same period to ₹0.09Cr in the Q1 2024-2025. On a quarterly growth basis, Biogen Pharmachem Industries Ltd has generated -111.54% fall in its revenue since last 3-months.
Net Profits:
Biogen Pharmachem Industries Ltd’s net profit fell -139.02% since last year same period to ₹0.16Cr in the Q1 2024-2025. On a quarterly growth basis, Biogen Pharmachem Industries Ltd has generated -121.62% fall in its net profits since last 3-months.
Net Profit Margins:
Biogen Pharmachem Industries Ltd’s net profit margin jumped 225.2% since last year same period to 177.78% in the Q1 2024-2025. On a quarterly growth basis, Biogen Pharmachem Industries Ltd has generated 87.39% jump in its net profit margins since last 3-months.
